| Dr John H Lacy, MD | |
|
130 Daniel Dr, Danville, KY 40422-2527 | |
| (859) 236-2222 | |
| (859) 236-2227 |
| Full Name | Dr John H Lacy |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 41 Years |
| Location | 130 Daniel Dr, Danville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053461715 | NPI | - | NPPES |
| 64264567 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 26456 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mcdowell Home Health Agency | Danville, KY | Home health agency |
| The James B. Haggin Memorial Hospital | Harrodsburg, KY | Hospital |
| Ephraim Mcdowell Regional Medical Center | Danville, KY | Hospital |
| Ephraim Mcdowell Fort Logan Hospital | Stanford, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ephraim Mcdowell Health Resource Inc | 7517876956 | 115 |
News Archive
The complete agenda for the Seventh International Chronic Total Occlusion (CTO) Summit is now available online at http://www.ctosummit.org/overview/agenda.html. The CTO Summit is a two-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions.
A new article looks at how currently available drugs for various conditions might be repurposed alone or in combination with other drugs to treat infectious diseases.
A next-generation genome editing system developed by Massachusetts General Hospital investigators substantially decreases the risk of producing unwanted, off-target gene mutations. In a paper receiving online publication in Nature Biotechnology, the researchers report a new CRISPR-based RNA-guided nuclease technology that uses two guide RNAs, significantly reducing the chance of cutting through DNA strands at mismatched sites.
Scientific breakthroughs in the study of the human genome coupled with online access to massive genealogical records have opened the doors of ancestral investigation to include all those interested in unearthing their roots and, on October 26-27 at the Metropolitan Pavilion in New York City, The Genealogy Event will feature exciting learning opportunities and resources for both novice and professional enthusiasts.
› Verified 3 days ago
| Entity Name | Ephraim Mcdowell Health Resource Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487708533 PECOS PAC ID: 7517876956 Enrollment ID: O20031218000776 |
News Archive
The complete agenda for the Seventh International Chronic Total Occlusion (CTO) Summit is now available online at http://www.ctosummit.org/overview/agenda.html. The CTO Summit is a two-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions.
A new article looks at how currently available drugs for various conditions might be repurposed alone or in combination with other drugs to treat infectious diseases.
A next-generation genome editing system developed by Massachusetts General Hospital investigators substantially decreases the risk of producing unwanted, off-target gene mutations. In a paper receiving online publication in Nature Biotechnology, the researchers report a new CRISPR-based RNA-guided nuclease technology that uses two guide RNAs, significantly reducing the chance of cutting through DNA strands at mismatched sites.
Scientific breakthroughs in the study of the human genome coupled with online access to massive genealogical records have opened the doors of ancestral investigation to include all those interested in unearthing their roots and, on October 26-27 at the Metropolitan Pavilion in New York City, The Genealogy Event will feature exciting learning opportunities and resources for both novice and professional enthusiasts.
› Verified 3 days ago
| Entity Name | Central Kentucky Surgeons, Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114079555 PECOS PAC ID: 6608840723 Enrollment ID: O20040824001112 |
News Archive
The complete agenda for the Seventh International Chronic Total Occlusion (CTO) Summit is now available online at http://www.ctosummit.org/overview/agenda.html. The CTO Summit is a two-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions.
A new article looks at how currently available drugs for various conditions might be repurposed alone or in combination with other drugs to treat infectious diseases.
A next-generation genome editing system developed by Massachusetts General Hospital investigators substantially decreases the risk of producing unwanted, off-target gene mutations. In a paper receiving online publication in Nature Biotechnology, the researchers report a new CRISPR-based RNA-guided nuclease technology that uses two guide RNAs, significantly reducing the chance of cutting through DNA strands at mismatched sites.
Scientific breakthroughs in the study of the human genome coupled with online access to massive genealogical records have opened the doors of ancestral investigation to include all those interested in unearthing their roots and, on October 26-27 at the Metropolitan Pavilion in New York City, The Genealogy Event will feature exciting learning opportunities and resources for both novice and professional enthusiasts.
› Verified 3 days ago
| Entity Name | Ephraim Mcdowell Regional Medical Center Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316141351 PECOS PAC ID: 3375506447 Enrollment ID: O20041109001051 |
News Archive
The complete agenda for the Seventh International Chronic Total Occlusion (CTO) Summit is now available online at http://www.ctosummit.org/overview/agenda.html. The CTO Summit is a two-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions.
A new article looks at how currently available drugs for various conditions might be repurposed alone or in combination with other drugs to treat infectious diseases.
A next-generation genome editing system developed by Massachusetts General Hospital investigators substantially decreases the risk of producing unwanted, off-target gene mutations. In a paper receiving online publication in Nature Biotechnology, the researchers report a new CRISPR-based RNA-guided nuclease technology that uses two guide RNAs, significantly reducing the chance of cutting through DNA strands at mismatched sites.
Scientific breakthroughs in the study of the human genome coupled with online access to massive genealogical records have opened the doors of ancestral investigation to include all those interested in unearthing their roots and, on October 26-27 at the Metropolitan Pavilion in New York City, The Genealogy Event will feature exciting learning opportunities and resources for both novice and professional enthusiasts.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John H Lacy, MD 130 Daniel Dr, Danville, KY 40422-2527 Ph: (859) 236-2222 | Dr John H Lacy, MD 130 Daniel Dr, Danville, KY 40422-2527 Ph: (859) 236-2222 |
News Archive
The complete agenda for the Seventh International Chronic Total Occlusion (CTO) Summit is now available online at http://www.ctosummit.org/overview/agenda.html. The CTO Summit is a two-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions.
A new article looks at how currently available drugs for various conditions might be repurposed alone or in combination with other drugs to treat infectious diseases.
A next-generation genome editing system developed by Massachusetts General Hospital investigators substantially decreases the risk of producing unwanted, off-target gene mutations. In a paper receiving online publication in Nature Biotechnology, the researchers report a new CRISPR-based RNA-guided nuclease technology that uses two guide RNAs, significantly reducing the chance of cutting through DNA strands at mismatched sites.
Scientific breakthroughs in the study of the human genome coupled with online access to massive genealogical records have opened the doors of ancestral investigation to include all those interested in unearthing their roots and, on October 26-27 at the Metropolitan Pavilion in New York City, The Genealogy Event will feature exciting learning opportunities and resources for both novice and professional enthusiasts.
› Verified 3 days ago
John E Merryman, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 130 Daniel Dr, Danville, KY 40422 Phone: 859-236-2222 Fax: 859-236-2227 | |
Katrina Ann Kolasa, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 130 Daniel Dr, Danville, KY 40422 Phone: 859-236-2222 | |
Mr. Paul P Deluca, MD Surgery Medicare: Medicare Enrolled Practice Location: 130 Daniel Drive, Danville, KY 40423 Phone: 859-236-2222 Fax: 859-236-2227 | |
Barry A Spoonamore, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 210 W Main St, Danville, KY 40422 Phone: 859-236-0712 Fax: 859-236-7858 | |
David O Montgomery, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 210 W Main St, Danville, KY 40422 Phone: 859-236-0712 Fax: 859-236-7858 |